TIMP1 is markedly expressed in CRC tumors, and elevated TIMP1 expression is associated with unfavorable clinical outcomes in CRC patients (Kobayashi et al., 2015; Lee et al., 2011). The gene discussed is TIMP1; the disease is colorectal carcinoma.